Apixaban in Thrombocytopenia

Clinical trial NCT06886516 · RECRUITING

Trial details

NCT number: NCT06886516
Sponsor: Rushad Patell
Status: RECRUITING
Phase: Early Phase 1
Study type: INTERVENTIONAL

Deep Vein Thrombosis Pulmonary Embolism and Thrombosis Thrombocytopenia Recurrent Venous Thromboembolism

Start date: 2025-02-28
Primary completion: 2027-07-01
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.